ask="N/A"
ask_size="N/A"
average_daily_volume="2342770"
bid="N/A"
bid_size="N/A"
book_value="-0.151"
change="-0.005"
change_from_200_day_moving_average="0.051"
change_from_50_day_moving_average="0.180"
change_from_52_week_high="-0.385"
change_From_52_week_low="0.315"
change_in_percent="-0.811%"
close="0.575"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.464"
ebitda="-30.10M"
eps_estimate_current_year="-0.380"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.270"
ex_dividend_date="N/A"
float_shares="71947000"
high="0.585"
high_52_weeks="0.960"
last_trade_date="1/25/2017"
last_trade_price="0.575"
last_trade_size="1131"
last_trade_time="4:04pm"
low="0.551"
low_52_weeks="0.260"
market_capitalization="57.40M"
moving_average_200_day="0.524"
moving_average_50_day="0.395"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.600"
open="0.585"
pe_ratio="1.239"
peg_ratio="-0.060"
percent_change_from_200_day_moving_average="+9.675%"
percent_change_from_50_day_moving_average="+45.737%"
percent_change_from_52_week_high="-40.104%"
percent_change_from_52_week_low="+121.154%"
previous_close="0.580"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="8.130"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="0.110"
stock_exchange="ASE"
symbol="PLX"
volume="1556603"
weeks_range_52="0.260 - 0.960"
